Stay updated on Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the study page content and layout appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T13:48:02.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Major update: announces funding-related service caveats and confirms NIH Clinical Center is open, plus version increment to v3.2.0; drops the old v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T04:23:52.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Updated page to revision v3.1.0 with new contact details (phone numbers and emails) replacing the previous v3.0.2; core content remains largely the same, with emphasis on updated versioning and new contact information.
    Difference
    0.1%
    Check dated 2025-09-28T23:42:54.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No changes to core content, pricing, stock, or time-sensitive information.
    Difference
    0.2%
    Check dated 2025-09-14T09:51:17.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T07:53:55.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various proteins and antibodies, while removing several terms related to locations and specific types of antineoplastic agents.
    Difference
    2%
    Check dated 2025-08-31T01:02:13.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in Basal Cell Carcinoma Clinical Trial page.